BIOMARIN PHARMACEUTICAL INC (BMRN) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Operating Income (Loss) for the quarter ending March 31, 2024 was $88.5 M, a 41.8% increase year-over-year.
  • Biomarin Pharmaceutical Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was $184 M, a 147% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2023 was $158 M, a 5.71% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2022 was $150 M.
  • Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2021 was -$82.3 M, a 89.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $184 M $88.5 M +$26.1 M +41.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $158 M $11.2 M +$35.7 M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $122 M $25.7 M +$28.1 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $94.4 M $58.9 M +$19.7 M +50.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $74.6 M $62.4 M -$74.9 M -54.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $150 M -$24.5 M +$41.4 M +62.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $108 M -$2.42 M +$50.8 M +95.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $57.4 M $39.2 M +$27.5 M +235% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $29.9 M $137 M +$112 M +447% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$82.3 M -$65.9 M -$14.4 M -27.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$68 M -$53.2 M +$2.72 M +4.87% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 -$70.7 M $11.7 M +$52.6 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$123 M $25.1 M -$79.9 M -76.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 -$43.4 M -$51.5 M -$42.4 M -462% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$1.09 M -$55.9 M -$60 M -1495% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $58.9 M -$40.9 M +$409 K +0.99% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $58.5 M $105 M +$159 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$100 M -$9.16 M +$29 M +76% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$129 M $4.01 M +$19.8 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$149 M -$41.4 M -$16.1 M -63.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$133 M -$54 M -$9.58 M -21.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$124 M -$38.1 M -$96.2 M -166% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$27.3 M -$15.7 M -$2.01 M -14.7% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 -$25.3 M -$25.3 M +$13.5 M +34.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$38.9 M -$44.4 M -$24.2 M -120% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$14.7 M $58 M +$148 M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$162 M -$13.7 M +$46.4 M +77.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 -$209 M -$38.8 M +$534 M +93.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$743 M -$20.2 M +$60.7 M +75% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$803 M -$89.6 M -$191 M -188% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$612 M -$60.1 M +$21.8 M +26.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$634 M -$573 M -$509 M -791% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$126 M -$80.9 M -$15.1 M -22.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$111 M $101 M +$160 M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$271 M -$81.9 M -$93.1 M -831% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$178 M -$64.3 M -$45.4 M -240% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$132 M -$65.9 M -$39.4 M -149% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 -$92.9 M -$58.8 M -$6.45 M -12.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$86.4 M $11.2 M +$61.9 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 -$148 M -$18.9 M +$1.17 M +5.84% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$150 M -$26.5 M +$6.47 M +19.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$156 M -$52.3 M -$5.41 M -11.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$151 M -$50.7 M -$40.2 M -384% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$110 M -$20.1 M +$10.9 M +35.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$121 M -$32.9 M -$11.1 M -50.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 -$110 M -$46.9 M -$25.5 M -119% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$84.7 M -$10.5 M +$5.03 M +32.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 -$89.8 M -$31 M -$31.7 M -4130% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 -$58.1 M -$21.9 M -$24.2 M -1053% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 -$33.9 M -$21.4 M -$18.1 M -540% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 -$15.8 M -$15.5 M -$13.6 M -700% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 -$2.23 M $768 K -$2.28 M -74.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $48 K $2.29 M -$496 K -17.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 $544 K -$3.35 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 -$1.94 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $3.04 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $2.79 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.